Abstract-We report an agglutination-based immunosensor for the quantification of C-reactive protein (CRP). The developed immunoassay sensor requires approximately 15 minutes of assay time per sample and provides a sensitivity of 0.5 mg/L. We have measured the capacitance of interdigitated electrodes (IDEs) and quantified the concentration of added analyte. The proposed method is a label free detection method and hence provides rapid measurement preferable in diagnostics. We have so far been able to quantify the concentration to as low as 0.5 mg/L and as high as 10 mg/L. By quantifying CRP in serum, we can assess whether patients are prone to cardiac diseases and monitor the risk associated with such diseases. The sensor is a simple low cost structure and it can be a promising device for rapid and sensitive detection of disease markers at the point-of-care stage.
I. INTRODUCTION
Immunoassays are crucial and versatile analytical tools with a wide range of application in the field of clinical diagnostics, forensics and biomolecular research. Researchers make concerted efforts to detect ultrasensitive [1] , label-free [2] simple and high throughput [3] assays. Small amounts of biomarkers are detected via quantitative immunoassays in physiological fluids [4] . These assays are used in detecting environmental contaminants [5] and infectious or toxic substances [6] and monitoring therapeutic drugs [7] . Traditional assays like cards and slides or conventional assays that are usually performed in micro well plates have several shortfalls that include complexities in fluids handling, requirement for large sample volumes and increased assay time. These demerits have limited the use of traditional and conventional systems in diagnostics [8] - [10] . Another disadvantage of these systems is the need for fluorescent labeling, which is tedious and time consuming practice. Therefore developing a device that can save time and simplify the process of sample preparation could be useful at the point-of-care.
The biosensors area is considered an emerging field. Although, a multitude of instruments is used as biosensors, they can be found mainly in labs. There is only one wellknown example of a low-cost portable point of care device; the glucose sensor [11] . Thus, this research area is fuelled by the need for portability, miniaturization and low-cost biosensors in order to avoid the usage of expensive equipment, which also requires a special user or doctor increasing the cost even further. Electrochemical biosensors are capable of directly transforming the biological information into an electrical signal. This fact leads to a less complex setup in the information extraction. Moreover, this biosensor type is robust and compatible with microelectronic circuits leading to cost and size decrease.
Quantitative analysis of certain proteins is crucial in clinical applications as it aids in diagnosing specific diseases. One such diagnostic protein is CRP, which was discovered in 1930 by Tillett and Francis [12] . These investigators identified a substance in the blood of patients with acute pneumococcal pneumonia that reacted with the cell wall C-polysaccharide of the bacteria . It is an acutephase serum protein and a member of the pentraxin protein family. It has a mass of 120 kDa and it is composed of five identical polypeptide subunits held together by noncovalent interactions. Its host defense functions predate the adaptive immune system by millions of years. The structure of CRP has been determined by X-ray crystallography at 3 Å resolution [13] [14] . The overall dimensions of the CRP pentamer are about 102 Å outside diameter with a central pore diameter of 30 Å and a protomer diameter of 36 Å. CRP is an inflammation and cardiac disease marker. Thus, detecting it is crucial because various concentrations present in human serum indicate an increased risk or even the presence of cardiac disease [15] .
Capacitive immunoassays are promising alternatives to immunochemical tests for the development of point-of-care devices. The analytes are bound to the antibody latex reagent that had been immobilized on the electrode surface. The change in capacitance, when the analytes bind to the antibody complex, is measured and this entire set up is typically termed as capacitive biosensors. By measuring the ratio of the capacitance in the final measurement to the first one before the process starts, we obtain an indication of the analyte. This ratio can be simplified into the relative permittivity of the anti-CRP antibody and CRP antigen interaction film since this is the primary reason for this capacitance difference. We have developed a capacitive immunosensor for accurate, rapid and cost-effective diagnosis of diseases at the point-of-care.
This work cannot be directly compared to the cases of [16] - [18] from the results perspective since a Network analyzer (NA) has been used. The main goal in our measurements is to achieve reliable capacitance readout. The LCR meter usage in the current work is used as a proof of concept for CRP quantification, which can pave the way for a fully integrated microsystem by using a simple IC circuitry for capacitance readout [19] - [21] . This cannot occur in the case of the NA, which is a complicated and expensive instrumentation typically present in a laboratory setting. Moreover, in our case, we took advantage of agglutination phenomena for forming the complex, which has significantly simplified the experimental process. Thus, simple instrumentation and fast procedure can have potentials for a portable application. Capacitive immunosensor for C-reactive protein quantification
II. MATERIALS AND METHODS

A. Interdigitated electrodes (IDEs) Fabrication
The IDEs were fabricated in the KAUST Nanofab using a 4-inch <100> p-type silicon wafer of 2.5-4.0 Ω·cm electrical resistivity from MEMC. A 2 um oxide layer was thermally grown for electrical isolation. This oxidized silicon wafer was selected to imitate IDEs grown in a standard CMOS process. The IDEs were patterned using a subtractive process, which gives better results compared to lift-off, given the thin and long IDEs fingers.
First, 10 nm Ti and 300 nm Au metal layers were deposited via physical vapor deposition (PVD) for 60 s and 360 s respectively in an ESC reactive and metal sputter system. Ti was used as an adhesion layer rather than Cr because it is more easily dry etched. The selection of Au is based on its favorable chemical and electrical characteristics. For both metals, the rest recipe is the same: 400 W of DC power, 25 sccm of Ar flow, pressure of 5 mTorr and pre-sputtering time of 30 s.
In the next step, optical lithography was used to pattern the electrodes. An image reversal photoresist (AZ5124E) was spun at 3000 rpm for 30 s yielding a 1.6 um photoresist layer, followed by soft baking at 105 o C for 120 s. A 5-inch dark-field optical mask was created using a Heidelberg uPG101 Laser Mask Writer. The photoresist was patterned using contact lithography and a 90 mJ/cm 2 broadband exposure dose. For image reversal, the wafer was then heated again at 120 o C for 120 s followed by flood exposure. Puddle developing for 60 s using AZ726 was performed in SUSS MicroTec Delta 12AQ spray develop system.
The metal layer was patterned by dry etching using the Oxford Instruments PlasmaLab System. A 30 sccm flow of Ar was used for 4 min with 150 W RF power and 1000 W ICP power. The exposed oxide thickness was further verified using the Nanospec 6100 Reflectometer to ensure that the metal layer was properly etched. Dry etching prevented the acetone from completely stripping the photoresist layer and thus O 2 plasma had to be used. The O 2 plasma step also partially etches the oxide between the IDEs fingers. This enhances the sensitivity because the agglutination complex fills completely the region between the fingers, which increases the maximum electric field. The IDEs were designed with 4 um finger width and 3 um spacing. For our cleanroom photolithography tools, this was the minimum reliable feature that could provide high capacitance.
Finally, the capacitive structure was coated with a 350 nm thin film of Parylene C by chemical vapor deposition (CVD). The coating was conformal with the thickness to be controllable by the recipe and the inserted Parylene C powder. In our case, 0.6 gram of Parylene C powder was used in order to achieve the thickness of 350 nm. This step enhanced the capacitors isolation and kept its dissipation factor to acceptable levels after depositing the analyte. Schematic representation of the fabricated IDEs cell in 2D and 3D using an optical microscope and the Nanosurf Easyscan 2 AFM are illustrated in Fig. 1 and Fig. 2 respectively. The whole cleanroom fabrication process is depicted in Fig. 3 . 
B. Experimental Procedure
From the biological sensor definition, it is an analytical device that converts a biological response into an electrical signal by combining a biological component with a physicochemical detector. In our case, the transducer was a gold IDEs array coated with 350 nm of Parylene C. Efforts have been made to improve upon agglutination assays for their potential in detecting biomarkers. Biomarkers provide insight into normal biological processes, pathogenic processes and pharmacological therapeutic interventions. The agglutination process occurs when anti-CRP antibodies interact with CRP protein (antigen). In general, agglutination takes place when an antigen is in a mixture with its corresponding antibody called isoagglutinin. The degree of agglutination depends on the concentration of antigen added to a specific concentration of antibody and vice versa. The whole process is illustrated in Fig. 4 .
Anti-CRP antibodies coated on the latex beads were employed throughout the experiments. Commercially available CRP (Applied Chem) of human serum was diluted to obtain various concentration of CRP. At first the antibodies were immobilized and then the antigens were introduced to form an agglutination complex. A precision pipette was used for introducing the complex and evenly distributing it across the IDEs. The capacitance was measured throughout the experiment duration. The main focus was on the values before the antibody immobilization and following the point where the complex was almost agglutinated, when the capacitance was in its highest value. An LCR meter (Keysight E4980a) was utilized at a frequency of 1 MHz at 1 V. The overall capacitance in the readout of the sensor can be modeled, as also depicted in Fig. 5 , by a fringing and a sidewall capacitance between the electrodes through the agglutination complex. There is also a background offset fringing capacitance through SiO 2 and Si, which can be considered equal for all the test samples since the same fabrication process was followed.
Cleaning has been conducted to the samples using DI H 2 O to investigate any possibility for reusability. The main obstacle for reusing was the fact that the Parylene C layer has been affected leading the isolation to degrade. Thus, new samples were used for each trial in order to obtain reliable and comparable results throughout the experiments with the different CRP concentrations. 
III. RESULTS AND DISCUSSION
After the immobilization of the anti-CRP antibodies, the IDEs capacitance increased as expected due to the dielectric constant of the antibody. The same fact occurred after the antigen injection, constituting the agglutination complex. This enhancement is based on the fringing and sidewall field that passes through the complex.
The results indicated the process of agglutination started immediately after analyte introduction and agglutination was progressing with time. For instance, agglutination with change over time for the concentration of 2 mg/L is depicted using film images in Fig. 6a . The changes of agglutination complex with time are represented by measuring the capacitance in Fig. 6b . During this process up until it is fully agglutinated, the capacitance value showed a slow increasing trend in the graph. This behavior was predictable since the antibodies are clumping antigens and the material properties vary. After reaching the highest value, the complex was completely formed. The capacitance value is decreased since evaporation occurred and caused changes in the properties of the mixture.
The concentrations were chosen based on the risk at which a patient can be prone to cardiac disease. According to the American Heart Association (AHA) and the United States Center for Disease Control (CDC), a CRP concentration below 1.0 mg/L represents low risk; a range from 1.0 to 3.0 mg/L represents medium (average) risk; a measurement over 3.0 mg/L represents high risk. Thus, the concentrations of 0.5 mg/L, 2 mg/L, 4 mg/L and 10 mg/L were selected as these assess the risk according to the aforementioned limits.
Analytes were added and the measured capacitance gave an indication of the analyte concentration, with an average of three trials per sample. The relative permittivity versus the antigen concentration is plotted in Fig. 7 . The detection limit for CRP detection is found to be 0.5 mg/L, which applies to the low risk limits. We see for the 0.5 mg/L, 2 mg/L and 4 mg/L of analyte concentration that the relative permittivity (e r ) increases. On the other hand, there is a slight decrease in the e r from 4 mg/L to 10 mg/L. This fact is based on the Hook effect. Hook effect is a common phenomenon in agglutination assays wherein it shows false negative results even in the presence of excess analyte, which has also occurred in [22] for CRP quantification. More specifically, the excess amount of antigen in the sample cannot be bound with the coated antibodies and this leads to no agglutination. Therefore, it behaves as if a lower concentration were added, which explain capacitance value corresponding to 10 concentration compared to 4 mg/L. 
